Technological advances have reduced genome sequencing costs to $600, boosting growth in the genomics sector. The genetic testing market is forecast to hit $91.3 billion by 2034, enhancing disease ...

Whether as a sponsor or donor, a member or volunteer, or an employee or fellow, you can make a difference. Integrating genomics at the population health level has the potential to increase our ...

How do evolutionary processes affect the genome? The field of population genomics surveys patterns in the genome within and among populations to make inferences about evolution and the genome.

Such questions are fundamental to the study of behavioral genomics. Aa Aa Aa The first systematic studies of whether human behaviors are hereditary were conducted over 100 years ago by Sir Francis ...

The Bindley Core for Genomics (BCG) does Illumina MiSeq full or partial runs and a range of quality control assays on instruments such as the Agilent TapeStation and the ThermoFisher Qubit.

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument! This will expand our capacity of services already offered for NGS. Feel free to call or email us to find ...

The Medical Genomics Laboratory (MGL) is a CAP-certified nonprofit clinical laboratory at the University of Alabama at Birmingham, offering comprehensive testing for common and rare genetic conditions ...

The Single Cell Genomics Core is dedicated to advancing research through cutting-edge single-cell analysis technologies. We offer a range of services, including single cell RNA sequencing and spatial ...

The genomics lab provides next-generation DNA sequencing capabilities to both departmental research and classrooms in the College of Science. The facility features an Illumina Miseq, a platform ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...